论文部分内容阅读
目的探究前列地尔干乳剂治疗糖尿病下肢血管病变的临床应用价值。方法 46例糖尿病下肢血管病变患者,随机分成对照组和实验组,各23例。对照组采用阿司匹林治疗,实验组采用前列地尔干乳剂治疗,观察两组患者治疗前后血脂变化及临床症状改善率。结果实验组临床症状改善率(86.96%)明显高于对照组(69.57%)(P<0.05);治疗后血脂变化情况优于对照组(P<0.05)。结论针对糖尿病下肢血管病变患者采用前列地尔干乳剂治疗的临床意义较大,能显著缓解患者的临床症状,改善血脂水平,值得推广。
Objective To investigate the clinical value of alprostadil dry emulsion in the treatment of diabetic lower limb vascular disease. Methods 46 cases of diabetic lower extremity vascular disease were randomly divided into control group and experimental group, each of 23 cases. The control group was treated with aspirin. The experimental group was treated with alprostadil dry emulsion, and the changes of blood lipid and the improvement of clinical symptoms before and after treatment were observed. Results The clinical symptom improvement rate (86.96%) in the experimental group was significantly higher than that in the control group (69.57%) (P <0.05). The change of blood lipid in the experimental group was better than that in the control group (P <0.05). Conclusion The clinical significance of Alprostadil dry emulsion for the treatment of lower extremity vascular disease in diabetic patients is significant, which can significantly alleviate the clinical symptoms and improve the level of blood lipid, which is worth promoting.